Post by
MrMugsy on Sep 10, 2022 9:07am
AGM ...
15% of the shares voted - tells me mostly insiders with 1M-2M outside shares voted. (max).
Roughly 8M of the 52M outstanding shares voted.
---------------
CITA could close soon.
Commercial study - have now and will review next week - share info in the next 2-3 weeks.
Antiviral is early stage - look beyond COVID to respiratory diseases in the future.
Phase 2 to start around September 28th and top-line expected before Christmas.
FDA Fast-track is a "one shot" deal so they need to get it right - confidence in the data to guide decision of when to apply
---------------
For those of you that want to hold me to the above timing - go to Hades.
For the rest of you ... enjoy !!!
Hahaha !